In patients with confirmed high risk PE (ie, with shock or hypotension) | |
ICCU admission | Is recommended |
Bolus and weight adjusted intravenous UFH infusion | Is recommended |
Vasopressive drugs to correct hypotension | Is recommended |
Oxygen to correct hypoxaemia | Is recommended |
Thrombolytic treatment | Is recommended |
Surgical embolectomy | Is recommended* |
Catheter embolectomy/fragmentation | May be considered* |
In patients with confirmed intermediate risk PE (ie, normotensive but with RV dysfunction and/or myocardial injury) | |
Weight adjusted subcutaneous LMWH or fondaparinux | Are recommended |
Intravenous UFH infusion if high bleeding risk/low GFR | Is recommended |
Admission to ICCU and thrombolytic treatment | May be considered |
In patients with confirmed low risk PE (ie, normotensive with neither RV dysfunction nor myocardial injury) | |
Weight adjusted subcutaneous LMWH or fondaparinux | Are recommended |
Intravenous UFH infusion if high bleeding risk/low GFR | Is recommended |
Home treatment after excluding comorbidities | May be considered |
In patients with confirmed PE and haemorrhagic complications or PE recurrence despite treatment | |
Permanent or retrievable vena cava filter | Should be considered |
↵* If thrombolysis fails or is contraindicated.
GFR, glomerular filtration rate; ICCU, intensive cardiac care unit; LMWH, low molecular weight heparins; RV, right ventricle; UFH, unfractionated heparin.